stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. OMDA
    stockgist
    HomeTop MoversCompaniesConcepts
    OMDA logo

    Omada Health

    OMDA
    NASDAQ
    Healthcare
    Medical - Healthcare Information Services
    San Francisco, CA, US849 employeesomadahealth.com
    $12.69
    +0.08(0.63%)

    Mkt Cap $748M

    $10.94
    $26.78

    52-Week Range

    At a Glance

    AI-generated

    Omada Health (OMDA) reported FY 2025 total revenue of $260.2M, up 53% YoY from $169.8M in 2024, driven by 55% growth in total members to 886,000 from 572,000, reflecting strong customer acquisition and program expansion in cardiometabolic and MSK offerings.

    Revenue breakdown: Service (92.9%), Hardware (7.1%).

    8-K
    Omada Health reported Q4 2025 revenue of $76 million (up 58% YoY) and full-year revenue of $260 million (up 53% YoY), achieving positive net income of $5 million in Q4 and positive Adjusted EBITDA of $6 million for the year. The company issued 2026 guidance for revenue of $312-322 million and Adjusted EBITDA of $7-15 million.

    $748M

    Market Cap

    $262M

    Revenue

    -$13M

    Net Income

    Employees849
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Service92.9%($822M)
    Hardware7.1%($62M)
    Activity

    What Changed Recently

    Financial Results
    Mar 4, 2026

    of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the

    Financial Results
    Jan 11, 2026

    of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    TXG10x Genomics, Inc.$22.30+1.16%$2.8B-55.9
    BCRXBioCryst Pharmaceuticals,...$9.03-3.78%$1.9B7.8
    OMCLOmnicell, Inc.$34.15+0.60%$1.6B751.7
    UFPTUFP Technologies, Inc.$191.22-1.43%$1.5B21.3
    MAZEMaze Therapeutics, Inc.$28.82-0.77%$1.4B-17.8
    PGNYProgyny, Inc.$16.60-1.54%$1.4B26.2
    XERSXeris Biopharma Holdings,...$6.03-0.25%$1.0B1680.6
    TDOCTeladoc Health, Inc.$5.28-0.09%$941M-4.8
    Analyst View
    Company Profile
    CIK0001611115
    ISINUS68170A1088
    CUSIP68170A108
    Phone888 987 8337
    Address500 Sansome Street, San Francisco, CA, 94111, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice